Ajanta Pharma Ltd. benchmarking: Perfomance to industry peers

Financial

	Ajanta Pharma	Ipca Laboratories	Gland Pharma
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	75.0 .	44.0 .	384.0 .
Number of ANDA's Approved By USFDA	56.0 .	31.0 .	331.0 .
Domestic Sales Growth - YoY	7.5 %	13.1 %	n/a
R&D as a % of Total Sales	5.0 %	3.12 %	5.4 %
Financials
5 yr Average ROE	21.63 %	13.55 %	12.02 %
5yr average Equity Multiplier	1.32	1.52	1.15
5yr Average Asset Turnover Ratio	0.84	0.76	0.51
5yr Avg Net Profit Margin	19.77 %	11.88 %	20.79 %
Price to Book	8.07	4.92	3.27
P/E	34.32	43.92	36.9
5yr Avg Cash Conversion Cycle	-102.34 Days	54.3 Days	69.81 Days
Inventory Days	55.16 Days	102.83 Days	118.26 Days
Days Receivable	49.8 Days	72.68 Days	99.92 Days
Days Payable	195.69 Days	111.38 Days	107.43 Days
5yr Average Interest Coverage Ratio	108.5	50.79	183.05
5yr Avg ROCE	27.48 %	17.31 %	16.55 %
5yr Avg Operating Profit Margin	27.65 %	19.8 %	29.26 %
5 yr average Debt to Equity	0.0	0.17	0.01
5yr CAGR Net Profit	7.08 %	-8.34 %	-6.87 %
5yr Average Return on Assets	16.51 %	9.41 %	10.65 %
Shareholdings
Promoter Holding	66.25 %	44.72 %	51.83 %
Share Pledged by Promoters	17.29 %	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.14 %	-1.57 %	-6.03 %
Change in Mutual Fund Holding (3 Yrs)	1.92 %	0.73 %	11.93 %

Business

	Ajanta Pharma	Ipca Laboratories	Gland Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 API 0 Generics 0 Branded Generics 0 Injectables 0 Pharmaceuticals 0	Product Wise Break-Up Branded Generics 50.39 Pharmaceutical 0 Pharmaceuticals 0 Formulations 33.08 Active Pharmaceutical Ingredient (API) 16.53 Injectables 0	Product Wise Break-Up Branded Generics 0 Pharmaceutical 0 Pharmaceutical 100.0 Generics 0 API 0 Injectables 0
Segment Break-Up	Segment Break-Up Others 100	-	-
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Dermatology 23.0 Pain 10.0 Neutraceuticals 0 Urology 0 Cough Preparations 0 Neuro Psychiatry 0 Gastro-Intestinal (GI) Products 0 Anti-Bacterials 0 Anti-Malarials 0 Cardiovasculars & Anti-Diabetics 0 0 Others 67.0	Therapeutic Area Wise Break-Up - Domestic Central Nervous System (CNS) 3.0 Dermatology 6.0 Neutraceuticals 1.0 Gastro Intestinal 2.0 Cardiac Science 17.0 Cough and colds 4.0 Pain 53.0 Anti-bacterial 5.0 Anti Malarials 3.0 Urology 5.0 0 Others 1.0	-
Location Wise Break-Up	Location Wise Break-Up India 32.26 USA 25.69 Asia Pacific 23.15 Africa 18.89 Asia (Excluding India) 0 Australia 0 CIS 0 Europe 0 Canada, Australia & New Zealand 0 Canada 0 Others 0.01	Location Wise Break-Up Europe 15.68 Canada 0 Asia Pacific 5.18 CIS 2.91 Canada, Australia & New Zealand 0 India 44.73 USA 21.58 Asia Pacific 0 Africa 6.72 Australia 3.2	Location Wise Break-Up Europe 19.15 Canada 0 Asia (Excluding India) 0 CIS 0 Canada, Australia & New Zealand 3.28 India 4.47 USA 55.68 Asia Pacific 0 Africa 0 Australia 0 Others 17.42
Asset Break-Up	Asset Break-Up India 98.73 USA 0.66 Asia Pacific 0.4 Africa 0.21	-	-

Ajanta Pharma Ltd.

Ajanta Pharma Ltd.

Financial

Business

SIGN UP FOR FREE